Home › Calculator › STOK Dividend Calculator 2026
STOK Dividend Calculator 2026
No dividendHealthcareStoke Therapeutics, Inc. · NASDAQ
Price: $25.04 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
STOK is not a dividend-focused stock
STOK pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
STOK Dividend Yield
Stoke Therapeutics, Inc. (STOK) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When STOK pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Stoke Therapeutics, Inc. (STOK) — Dividend Analysis 2026
Stoke Therapeutics, Inc. is an emerging biopharmaceutical company dedicated to developing innovative antisense oligonucleotide (ASO) therapies. Its primary focus is to target and address the fundamental causes of severe genetic disorders, particularly within the United States. The company employs its exclusive Targeted Augmentation of Nuclear Gene Output (TANGO) platform to engineer ASOs that precisely enhance protein expression. Stoke's most advanced candidate, STK-001, is currently progressing through Phase I/IIa clinical trials for Dravet syndrome, a severe and debilitating genetic epilepsy. Additionally, STK-002 is in the preclinical development stage for treating autosomal dominant optic atrophy. The company has also established a licensing and collaborative agreement with Acadia Pharmaceuticals Inc. to identify, develop, and market new RNA-based medicines for critical and rare genetic neurodevelopmental conditions impacting the central nervous system. Formerly known as ASOthera Pharmaceuticals, Inc., the company rebranded to Stoke Therapeutics, Inc. in May 2016. Founded in 2014, Stoke Therapeutics, Inc. maintains its headquarters in Bedford, Massachusetts.
STOK Dividend & DRIP — Frequently Asked Questions
Does STOK pay a dividend?
No. Stoke Therapeutics, Inc. (STOK) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of STOK?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does STOK have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. STOK has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to STOK
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full STOK DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open STOK position with:
🌍 STOK Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold STOK.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 STOK Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 STOK Dividend Payment Schedule
STOK pays quarterly — 4 times per year. Ex-div: —.
📊 STOK vs Healthcare Benchmarks
How STOK compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for STOK sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ STOK Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2026-10-02 | 627 | $26.33 | $16.5K | ||
| Sale | 2026-10-01 | 1,051 | $26.16 | $27.5K | ||
| A-Award | 2026-09-23 | 39,674 | $26.11 | $1.04M | ||
| Sale | 2026-09-01 | 3,945 | $30.51 | $120.4K | ||
| Sale | 2026-09-01 | 1,600 | $31.06 | $49.7K | ||
| M-Exempt | 2026-08-14 | 10,000 | — | — | ||
| Sale | 2026-08-18 | 4,525 | $32.01 | $144.8K | ||
| Sale | 2026-08-18 | 242 | $32.47 | $7.9K | ||
| M-Exempt | 2026-08-14 | 10,000 | — | — | ||
| M-Exempt | 2026-08-14 | 26,250 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Peer Group
Similar companies in the same sectorCompare STOK with peers: STOK vs ARDX · STOK vs BCRX · STOK vs NTLA
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the STOK dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Stoke Therapeutics, Inc. (STOK) is currently trading at $25.04, 38% below its 52-week high. It does not currently pay a regular dividend.
Does STOK Pay a Dividend? Stoke Therapeutics, Inc. Dividend Status
Stoke Therapeutics, Inc. (STOK) is a healthcare stock trading at $25.04. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest STOK News
LiveNews aggregated from public sources via Finnhub & RSS. For informational purposes only.
Projected your STOK DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.